We validated that aerosolized delivery of these two miRNAs can reduce the Tregs, increase CD4+ and CD8+ T cells within tumors and induce the proliferation and effector function of tumor-specific CD8+ T cells via targeting PD-1/PD-L1 immune checkpoint pathway. This evidence concerns the gene CD4 and neoplasm.